SpO2 Sensor Direct Connect Finger Adult Reusable 3 Foot Cord

Features

• PN 2053 is only compatible with patient monitors containing Masimo SET technology
• The compatible Masimo Devices include Radical-7, Rad-57, & Pronto
• Compatible OEM Devices include the Baxter/Welch Allyn Connex Spot Monitor (CSM) 7000 Series and Connex Vital Signs Monitor (CVSM) 6000 Series
• Masimo SET Pulse Oximetry has been shown to have unrivaled accuracy and reliability in more than 100 clinical studies
• Accurate During Motion - Before Masimo SET® pulse oximetry, false alarm rates were high, often due to motion and low perfusion
• With Masimo SET®, the rate of false alarms dropped by more than 80% and yet true alarm detection improved significantly
• Accurate During Low Perfusion: A recent peer-reviewed study found that for Masimo SET® SpO2, ARMS* accuracy was 1.37% in all subjects with normal perfusion and 1.64% in all subjects with low perfusion
• Accurate on All Skin Tones: A peer-reviewed publication demonstrated that Masimo RD SET sensors had only a 0.15% difference in bias between dark- and light-skinned subjects, which is not clinically significant because pulse oximeters only measure in whole numbers
• Further analysis showed that RD SET accurately measured SpO2 for both Black and White subjects not only when perfusion was normal but also during low perfusion
• Masimo SET® saves lives: A study conducted over 10 years on general floor patients being monitored with Masimo SET® while recovering from surgery found zero preventable deaths or brain damage from opioid-induced respiratory depression SET® as part of screening for critical congenital heart disease (CCHD) has been shown to significantly improve screening sensitivity
• Another study has shown that use of SET® led to an 80% reduction in the rate of retinopathy of prematurity (ROP, an eye disorder that can cause blindness in premature babies)
• Of particular note, in multiple studies, involving more than 300,000 newborns, use of SET® as part of screening for critical congenital heart disease (CCHD) has been shown to significantly improve screening sensitivity